The therapy features lasers and a drug made from deep sea bacteria, and does not cause severe side effects, BBC News reported. A clinical trial of 413 prostate cancer patients at 47 hospitals across Europe found that 49 percent had no remaining trace of cancer after undergoing the treatment.